Watch this page for announcements from other Athena Forum users.
Cannabis legalization in WA state brought a flurry of manufactured products that contain highly concentrated tetrahydrocannabinol (THC), the cannabinoid responsible for cannabis' mind-altering effects. In response, the University of Washington's Addictions, Drug & Alcohol Institute (ADAI) has been contracted by the Washington Health Care Authority (mandated by ESSB 5092) to explore and suggest policy solutions to the public health challenges associated with high-THC products. The ADAI… read more